Redeye Fight Cancer Seminar – Outlook 2022

 

The fight against cancer is one of the major focus areas in the global biotech industry. We have invited some of the leading Nordic companies in this field to give updates on their priorities, challenges, and expected progress during 2022.

 

The event will include an introduction to the theme by Redeye analysts Richard Ramanius and Christian Binder, giving an overview of the oncology landscape, key trends as well as commercial and regulatory activity.  

 

The company presentations include a Q&A section, with questions from the Redeye analyst and from viewers of the live broadcast.

 

Companies and schedule may change before the event starts.